FDA Clearance For DVS(R)-HFT, Next-Generation Wireless Sensor To Measure Actual Radia
 

Sicel Technologies, Inc. announced it has received clearance from the U.S. Food and Drug Administration to begin marketing DVS®-HFT, the next-generation of the company's original DVS (Dose Verification System) wireless implantable dosimeter that remains the only device to measure actual radiation dose at the tumor site for use in treating breast and prostate cancer patients undergoing external beam radiation therapy.

More...